↓ Skip to main content

Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia

Overview of attention for article published in BMC Psychiatry, October 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

blogs
1 blog
video
1 YouTube creator

Readers on

mendeley
141 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Published in
BMC Psychiatry, October 2013
DOI 10.1186/1471-244x-13-261
Pubmed ID
Authors

Steven Potkin, Rimal Bera, Donna Zubek, Gina Lau

Abstract

The research goal is to better understand prescriber, patient, and caregiver perspectives about long-acting injectable (LAI) antipsychotic therapy and how these perspectives affect LAI use. Addressing these perspectives in the clinic may lead to greater success in achieving therapeutic goals for the patient with schizophrenia.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Unknown 139 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 16%
Researcher 20 14%
Other 14 10%
Student > Ph. D. Student 13 9%
Student > Bachelor 11 8%
Other 25 18%
Unknown 36 26%
Readers by discipline Count As %
Psychology 27 19%
Medicine and Dentistry 24 17%
Nursing and Health Professions 16 11%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Social Sciences 6 4%
Other 20 14%
Unknown 42 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2023.
All research outputs
#5,673,408
of 23,578,918 outputs
Outputs from BMC Psychiatry
#1,936
of 4,901 outputs
Outputs of similar age
#49,335
of 212,130 outputs
Outputs of similar age from BMC Psychiatry
#42
of 91 outputs
Altmetric has tracked 23,578,918 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,901 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.7. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,130 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.